Literature DB >> 25689263

Dynamic increases in AMPA receptor phosphorylation in the rat hippocampus in response to amphetamine.

Li-Min Mao1, Bing Xue1, Dao-Zhong Jin1, John Q Wang1,2,3.   

Abstract

Increasing evidence supports the critical role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors in psychostimulant action. These receptors are regulated via a phosphorylation-dependent mechanism in their trafficking, distribution, and function. The hippocampus is a brain structure important for learning and memory and is emerging as a critical site for processing psychostimulant effects. To determine whether the hippocampal pool of AMPA receptors is regulated by stimulants, we investigated and characterized the impact of amphetamine (AMPH) on phosphorylation of AMPA receptors in the adult rat hippocampus in vivo. We found that AMPH markedly increased phosphorylation of AMPA receptor GluA1 subunits at serine 845 (S845) in the hippocampus. The effect of AMPH was dose dependent. A single dose of AMPH induced a rapid and transient increase in S845 phosphorylation. Among different hippocampal subfields, AMPH primarily elevated S845 phosphorylation in the Cornu Ammonis area 1 and dentate gyrus. In contrast to S845, serine 831 phosphorylation of GluA1 and serine 880 phosphorylation of GluA2 were not altered by AMPH. In addition, surface expression of hippocampal GluA1 was up-regulated, while the amount of intracellular GluA1 fraction was concurrently reduced in response to AMPH. GluA2 protein levels in either the surface or intracellular pool were insensitive to AMPH. These data demonstrate that the AMPA receptor in the hippocampus is sensitive to dopamine stimulation. Acute AMPH administration induces dose-, time-, site-, and subunit-dependent phosphorylation of AMPA receptors and facilitates surface trafficking of GluA1 AMPA receptors in hippocampal neurons in vivo. Acute injection of amphetamine increased phosphorylation of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor GluA1 subunits at a protein kinase A (PKA)-sensitive site (S845) in the rat hippocampus. This increase was dose- and time-dependent and correlated with an increase in surface GluA1 expression. Thus, amphetamine can upregulate GluA1 phosphorylation and surface trafficking of GluA1 in hippocampal neurons in vivo.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  CA1; GluA1; S831; S845; S880; dentate gyrus

Mesh:

Substances:

Year:  2015        PMID: 25689263      PMCID: PMC4464951          DOI: 10.1111/jnc.13067

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  82 in total

1.  Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.

Authors:  G L Snyder; P B Allen; A A Fienberg; C G Valle; R L Huganir; A C Nairn; P Greengard
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

2.  Alterations in AMPA receptor subunits and TARPs in the rat nucleus accumbens related to the formation of Ca²⁺-permeable AMPA receptors during the incubation of cocaine craving.

Authors:  Carrie R Ferrario; Jessica A Loweth; Mike Milovanovic; Kerstin A Ford; Gregorio L Galiñanes; Li-Jun Heng; Kuei Y Tseng; Marina E Wolf
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

Review 3.  The dopaminergic mesencephalic projections to the hippocampal formation in the rat.

Authors:  A Gasbarri; A Sulli; M G Packard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-01       Impact factor: 5.067

4.  Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons.

Authors:  Can Gao; Xiu Sun; Marina E Wolf
Journal:  J Neurochem       Date:  2006-06-27       Impact factor: 5.372

5.  Reinforcement-related regulation of AMPA glutamate receptor subunits in the ventral tegmental area enhances motivation for cocaine.

Authors:  Kwang Ho Choi; Scott Edwards; Danielle L Graham; Erin B Larson; Kimberly N Whisler; Diana Simmons; Allyson K Friedman; Jessica J Walsh; Zia Rahman; Lisa M Monteggia; Amelia J Eisch; Rachael L Neve; Eric J Nestler; Ming-Hu Han; David W Self
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

6.  Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation.

Authors:  Michael C Oh; Victor A Derkach; Eric S Guire; Thomas R Soderling
Journal:  J Biol Chem       Date:  2005-11-04       Impact factor: 5.157

7.  Dopamine in the hippocampus is cleared by the norepinephrine transporter.

Authors:  Anders Borgkvist; Torun Malmlöf; Kristin Feltmann; Maria Lindskog; Björn Schilström
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-14       Impact factor: 5.176

8.  Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons.

Authors:  R J Wenthold; R S Petralia; I I Blahos J; A S Niedzielski
Journal:  J Neurosci       Date:  1996-03-15       Impact factor: 6.167

9.  Modulation of dopamine mediated phosphorylation of AMPA receptors by PSD-95 and AKAP79/150.

Authors:  Richard D Swayze; Marie-France Lisé; Joshua N Levinson; Anthony Phillips; Alaa El-Husseini
Journal:  Neuropharmacology       Date:  2004-10       Impact factor: 5.250

10.  Neurochemical correlates of relapse to d-amphetamine self-administration by rats induced by stimulation of the ventral subiculum.

Authors:  Pornnarin Taepavarapruk; Anthony G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2003-03-25       Impact factor: 4.530

View more
  1 in total

1.  Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine.

Authors:  Marta Vicente-Rodríguez; Rosalía Fernández-Calle; Esther Gramage; Carmen Pérez-García; María P Ramos; Gonzalo Herradón
Journal:  Mediators Inflamm       Date:  2016-12-04       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.